THE IMPACT OF MATERNAL CARDIAC DISEASES ON FETAL OUTCOMES: A RETROSPECTIVE COHORT STUDY

Authors

  • ES SIDDIQUI Department of Obstetric and Gynaecology, Civil Hospital LUMHS Jamshoro, Pakistan
  • M ABBASI Department of Obstetric and Gynaecology, Civil Hospital LUMHS Jamshoro, Pakistan
  • MS KHOSA Department of Obstetric and Gynaecology, D.G.Khan Medical College Dera Ghazi Khan Punjab, Pakistan
  • R MOHSIN Department of Obstetric and Gynaecology, PEMH (Pak Emirates Military Hospital Rawalpindi), Pakistan
  • N JABEEN Department of Obstetric and Gynaecology Rawal Institute of Health Sciences, Islamabad, Pakistan
  • U SIDDIQUE Department of Obstetric and Gynaecology. Akhter Saeed Medical and Dental College and Hospital, Lahore, Pakistan
  • F KHATOON Department of Biochemistry, College of Medicine University of Hail, KSA

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.315

Abstract

This retrospective cohort study aimed to investigate the impact of maternal cardiac diseases on fetal outcomes at the Liaquat University of Medical & Health Sciences (LUMHS). The study was conducted over one year, from December 2018 to December 2019, and involved a sample size of 120 participants. The study utilized medical records of pregnant women with cardiac diseases who delivered at LUMHS over the past 5 years. The data collected included maternal demographic and medical history, fetal and neonatal outcomes, and other relevant medical information. Descriptive statistics were used to analyze the data and determine the prevalence of maternal cardiac diseases and their impact on fetal outcomes. Logistic regression analysis was used to identify risk factors associated with adverse fetal outcomes, such as preterm birth, low birth weight, stillbirth, and congenital anomalies. The results showed that 20% of pregnant women had cardiac disease, with rheumatic heart disease being the most common. Women with cardiac diseases were found to be at higher risk for adverse fetal outcomes, including preterm birth, low birth weight, stillbirth, and congenital anomalies. Logistic regression analysis revealed that maternal age, parity, and type of cardiac disease were significant predictors of adverse fetal outcomes. These findings emphasize the importance of early identification and managing maternal cardiac diseases to prevent adverse fetal outcomes. The study contributes to growing maternal and fetal health research, particularly in high-risk populations such as pregnant women with cardiac diseases. It underscores the need for multidisciplinary management involving obstetricians, cardiologists, and neonatologists to optimize maternal and fetal outcomes in this population.

Downloads

Download data is not yet available.

References

Marshall V, William, et al. "Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Hypertension: The Impact of Left Heart Disease." International Journal of Cardiology Congenital Heart Disease, vol. 8, 2022, p. 100354, https://doi.org/10.1016/j.ijcchd.2022.100354.

Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, Johnson M. Effect of maternal heart disease on fetal growth. Obstet Gynecol. 2011 Apr;117(4):886-891. doi: 10.1097/AOG.0b013e31820cab69. Erratum in: Obstet Gynecol. 2011 Aug;118(2 Pt 1):364. PMID: 21422861.

Koutrolou-Sotiropoulou P, Parikh PB, Miller C, Lima FV, Butler J, Stergiopoulos K. Impact of Heart Disease on Maternal and Fetal Outcomes in Pregnant Women. Am J Cardiol. 2015 Aug 1;116(3):474-80. doi: 10.1016/j.amjcard.2015.04.063. Epub 2015 May 9. PMID: 26059869.

Marshall V, William, et al. "Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Hypertension: The Impact of Left Heart Disease." International Journal of Cardiology Congenital Heart Disease, vol. 8, 2022, p. 100354, https://doi.org/10.1016/j.ijcchd.2022.100354.

Caruana M, O'Brien K, Colman JM. Maternal cardiac disease in pregnancy. Part 1: congenital heart disease. Obstet Med. 2010;3(1):10-16.

Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-521.

Sliwa K, Libhaber E, Elliott C, et al. Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa. Heart. 2014;100(24):1967-1974.

Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: Part I. J Am Coll Cardiol. 2016;68(4):396-410.

Roos-Hesselink JW, Ruys TP, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657-665.

Avila WS, Grinberg M, Snitcowsky R, et al. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome. Eur Heart J. 1995;16(4):460-464.

Gelson E, Gatzoulis MA, Steer PJ, Johnson MR. Heart disease and pregnancy. BMJ. 2006;332(7536):51-56.

Canobbio MM, Warnes CA, Aboulhosn J, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(8):e50-e87.

Ruys TP, Roos-Hesselink JW, Hall R, et al. Heart failure in pregnant women with cardiac disease: data from the ROPAC (Registry of Pregnancy and Cardiac Disease). J Am Heart Assoc. 2017;6(6):e005328.

Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006;113(4):51

Downloads

Published

2023-06-16

How to Cite

SIDDIQUI, E., ABBASI , M., KHOSA, M., MOHSIN, R., JABEEN , N., SIDDIQUE, U., & KHATOON , F. (2023). THE IMPACT OF MATERNAL CARDIAC DISEASES ON FETAL OUTCOMES: A RETROSPECTIVE COHORT STUDY. Biological and Clinical Sciences Research Journal, 2023(1), 315. https://doi.org/10.54112/bcsrj.v2023i1.315

Most read articles by the same author(s)